Patent US4357323A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4357323A Expired / Lapsed US ⏱️ 0.0 years remaining

Polysaccharide RBS substance and antitumor agent containing same

Assignee: Daicel Corp
•
Filing: 1980-08-01
•
Granted: 1982-11-02
•
Expires: 2000-08-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A polysaccharide RBS substance having the ultraviolet absorption spectrum depicted in FIG. 1 and the infrared absorption spectrum depicited in FIG. 2 is obtained from rice bran by extraction with hot water. These substances have been tested for anti-tumor activity against Sarcoma 180 ascites tumor and against Ehrlich ascites tumor and were determined to have anti-tumor activity against these tested tumors.

Inventors

  • 👤 Eichi Soma
  • 👤 Kohei Kobayashi
  • 👤 Takuro Karakawa
  • 👤 Shigeyoshi Kato
  • 👤 Kiichi Uchida

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 18:12
CPC Classifications
C; C08; C08B; C08B37/00; C08B37/0006; C08B37/0009; A; A61; A61P; A61P35/00

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 160 words
A polysaccharide RBS substance and pharmaceutically acceptable addition salts thereof (1) having the following properties: it does not pass through a semipermeable membrane; it is insoluble in alcohol, acetone, hexane, benzene, ethyl acetate, dimethylsulfoxide, ligroin, carbon tetrachloride, chloroform and ether, and is soluble or highly soluble in water; a 1% aqueous solution or suspension is neutral or slightly acidic; it reacts positively in the following reactions: the Molisch reaction, the anthrone-sulfuric acid reaction, the tryptophane-sulfuric acid reaction, the crystein-sulfuric acid reaction, the chromotrope-sulfuric acid reaction, the phenol-sulfuric acid reaction, the carbazole-sulfuric acid reaction, the biuret reaction, the ninhydrin reaction and the Lowry-Folin reaction; and negatively in the Elson-Morgan reaction and the starch-iodine reaction; it has the ultraviolet absorption spectrum depicted in FIG. 1 and the infrared absorption spectrum depicted in FIG. 2; and (2) containing glucose units as the sugar component, said glucose units being bonded by α-1,6 glucoside bonds as the main chain and said main chain is branched.
Claim 2
Dependent Claim 160 words
A polysaccharide RBS substance and pharmaceutically acceptable addition salts thereof (1) having the following properties: it does not pass through a semipermeable membrane; it is insoluble in alcohol, acetone, hexane, benzene, ethyl acetate, dimethylsulfoxide, ligroin, carbon tetrachloride, chloroform and ether, and is soluble or highly soluble in water; a 1% aqueous solution or suspension is neutral or slightly acidic; it reacts positively in the following reactions: the Molisch reaction, the anthrone-sulfuric acid reaction, the tryptophane-sulfuric acid reaction, the crystein-sulfuric acid reaction, the chromotrope-sulfuric acid reaction, the phenol-sulfuric acid reaction, the carbazole-sulfuric acid reaction, the biuret reaction, the ninhydrin reaction and the Lowry-Folin reaction; and negatively in the Elson-Morgan reaction and the starch-iodine reaction; it has the ultraviolet absorption spectrum depicted in FIG. 1 and the infrared absorption spectrum depicted in FIG. 2; and (2) containing glucose units as the sugar component, said glucose units being bonded by α-1,6 glucoside bonds as the main chain and said main chain is branched.
Claim 3
Dependent Claim 62 words
A pharmaceutical composition effective in inhibiting the growth of Sarcoma 180 ascites tumors, Erlich ascites tumors, and tumor cells (SV 40-transformed C3H-2K cells) consisting essentially of polysaccharide RBS substance and pharmaceutically acceptable acid-addition salts thereof in a pharmaceutically effective amount, and a pharmaceutically acceptable vehicle, said polysaccharide RBS substance (1) having the following properties: it does not pass through a semipermeable membrane;
Claim 4
Dependent Claim 62 words
A pharmaceutical composition effective in inhibiting the growth of Sarcoma 180 ascites tumors, Erlich ascites tumors, and tumor cells (SV 40-transformed C3H-2K cells) consisting essentially of polysaccharide RBS substance and pharmaceutically acceptable acid-addition salts thereof in a pharmaceutically effective amount, and a pharmaceutically acceptable vehicle, said polysaccharide RBS substance (1) having the following properties: it does not pass through a semipermeable membrane;
Claim 5
Dependent Claim 136 words
it is insoluble in alcohol, acetone, hexane, benzene, ethyl acetate, dimethylsulfoxide, ligroin, carbon tetrachloride, chloroform and ether, and is soluble or highly soluble in water; a 1% aqueous solution or suspension is neutral or slightly acidic; it reacts positively in the following reactions: the Molisch reaction, the anthrone-sulfuric acid reaction, the tryptophane-sulfuric acid reaction, the crystein-sulfuric acid reaction, the chromotrope-sulfuric acid reaction, the phenol-sulfuric acid reaction, the carbazole-sulfuric acid reaction, the biuret reaction, the ninhydrin reaction and the Lowry-Folin reaction; and negatively in the Elson-Morgan reaction and the starch-iodine reaction; it has the ultraviolet absorption spectrum depicted in FIG. 1 and the infrared absorption spectrum depicted in FIG. 2; and (2) containing glucose units as the sugar component, said glucose units being bonded by α-1,6-glucoside bonds as the main chain and said main chain is branched.
Claim 6
Dependent Claim 136 words
it is insoluble in alcohol, acetone, hexane, benzene, ethyl acetate, dimethylsulfoxide, ligroin, carbon tetrachloride, chloroform and ether, and is soluble or highly soluble in water; a 1% aqueous solution or suspension is neutral or slightly acidic; it reacts positively in the following reactions: the Molisch reaction, the anthrone-sulfuric acid reaction, the tryptophane-sulfuric acid reaction, the crystein-sulfuric acid reaction, the chromotrope-sulfuric acid reaction, the phenol-sulfuric acid reaction, the carbazole-sulfuric acid reaction, the biuret reaction, the ninhydrin reaction and the Lowry-Folin reaction; and negatively in the Elson-Morgan reaction and the starch-iodine reaction; it has the ultraviolet absorption spectrum depicted in FIG. 1 and the infrared absorption spectrum depicted in FIG. 2; and (2) containing glucose units as the sugar component, said glucose units being bonded by α-1,6-glucoside bonds as the main chain and said main chain is branched.

References Cited (Backward Citations)

US4090016A Cited
US4152170A Cited
US4221907A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-11-01 1986-05-03 1986-11-02 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-11-01 1990-05-03 1990-11-02 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-11-01 1994-05-03 1994-11-02 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag